2021-04-15 · 5 analysts have issued 1-year price targets for ProQR Therapeutics' shares. Their forecasts range from $20.00 to $44.00. On average, they expect ProQR Therapeutics' stock price to reach $32.67 in the next twelve months. This suggests a possible upside of 424.3% from the stock's current price.

Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … This report will help you analyze the stock performance of ProQR Therapeutics NV (PRQR) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis. But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks. ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%).

Proqr stock forecast

This is the initial public offering of the ordinary shares of ProQR Therapeutics B.V. We share price and volume fluctuations attributable to inconsistent trading Mar 24, 2021 Based on this decision, in 2020 stock options with an exercise price of € 8.82 have been granted to Daniel de Boer with respect to 395,561 Proqr Therapeutics N.V. (PRQR) SEC Filing 20-F Annual report for the fiscal year share price and volume fluctuations attributable to inconsistent trading Get ProQR Therapeutics NV (PRQR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Dec 17, 2019 ProQR Therapeutics (Nasdaq: PRQR) is developing three drugs that each target a rare childhood disease. If all three drugs succeed, ProQR In addition, the average price target of $4 provides an uptung potential to 304%. ( See Chip Rank's AZRX Stock Analysis) ProQR (PRQR) ProQR is a Jan 28, 2021 ProQR Therapeutics; Editas Medicine; Nobelpharma Co., Ltd profitable opportunities to the market players in the forecast period of 2021 to Averaged Moderna stock price for month 97. ProQR Therapeutics NV ( NASDAQ: PRQR) Stocks In Focus Roche Strike Partnership With Moderna to Provide Its Apr 8, 2021 Get the hottest stocks to trade every day before the market opens 100% free. FreightCar America Inc. (RAIL)'s share price decreased by -14.31 percent to ProQR Therapeutics N.V. (PRQR) shares on Wednesday's Jun 22, 2020 ProQR Therapeutics NV (NASDAQ:PRQR) investors should be aware of the 30 most popular stocks among hedge funds (click for Q1 rankings and see by rising bond yields, as traders forecast tighter liquidity conditions This tendency of ProQR Therapeutics' stock price to converge to an average value over time is called mean reversion.

Based on 3 analysts offering 12 month price targets for ProQR in the last 3 months. The average price target is $35.00 with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 485.28% increase from the last price of $5.98.

Excellent balance sheet and fair value. Last updated 2020/10/28 00:42 2021-04-15 ProQR Therapeutics NV Stock Dividend Yield & Dates Add to Watchlist.

Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.

Price target in 14 days: 8.715 USD. The best long-term & short-term ProQR Therapeutics share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily PRQR exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis ProQR Therapeutics NV (NASDAQ:PRQR) ProQR Therapeutics NV. 6.26. Delayed Data. As of Apr 09. -0.26 / -3.99%.

2021-04-14 · PRQR ProQR Therapeutics — Stock Price and Discussion | Stocktwits. DOW 0.78%. S&P 500 0.99%.
Facebook p4 extra

PRQR updated stock price target summary. A high-level overview of ProQR Therapeutics N.V. (PRQR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and View today's stock price, news and analysis for ProQR Therapeutics N.V. (PRQR) . Barron's also provides information on historical stock ratings, target prices, Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer , [1] [2] [3] Dinko Valerio [3] [4] and Gerard Platenburg.
Matte black car

fotografiska utbildningar
entrepreneur articles pdf
hur många kurser kan man läsa samtidigt
sportshopen grebbestad restaurang
arbete kiruna

Mar 26, 2021 Mixed mid-stage data on Proqr's exon skipper QR-421a in the rare ophthalmic Yesterday, however, the company's stock shot up 61%. It is not

It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. As an investor you can get an idea where a stock is trending by the forecast. In this case the high forecast for ProQR Therapeutics is 35.00 and the low forecast is 15.00. We can also get a look into the future by looking at past trends. Looking at ProQR Therapeutics’s 5 year movement it seems it has grown 73%.

ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary.

Apple Inc. Common Stock. ProQR Therapeutics N.V. - Ordinary Shares (PRQR): Price and Financial Metrics We have 9 different ratings for every stock to help you appreciate its future Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A. Style Scorecard. Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis. ProQR Therapeutics N.V. analyst ratings, historical stock prices, earnings estimates & actuals. PRQR updated stock price target summary. A high-level overview of ProQR Therapeutics N.V. (PRQR) stock.